Bright Minds Biosciences, Inc. (DRUG.CX)
98.07
-3.30
(-3.26%)
CAD |
CNSX |
Apr 01, 16:00
Bright Minds Biosciences Market Cap : 928.58M for April 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Fennec Pharmaceuticals, Inc. | 327.09M |
| Green Thumb Industries, Inc. | 2.159B |
| Lowell Farms, Inc. | 0.2722M |
| Wesana Health Holdings, Inc. | 0.1004M |
| Sharp Therapeutics Corp. | 67.67M |
Market Cap Related Metrics
| PEG Ratio | -0.0346 |
| Price to Book Value | 10.40 |
| Price | 98.07 |
| Earnings Yield | -2.85% |
| PEGY Ratio | -0.0346 |